Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Filings indexed 958 across all filing types
Latest filing 2017-01-03 Major Shareholding Noti…
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G
Major Shareholding Notification
2017-01-03 English
FORM 10-K/A
Annual Report FY 2016
2016-12-08 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text mentions an Item 8.01 Other Events section describing a press release about preliminary study results, and an Item 9.01 Financial Statements and Exhibits section referencing the press release as an exhibit. The document is short (2249 characters) and primarily serves as an announcement of an event and attached press release, not a full financial report or detailed filing. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-12-07 English
FORM 10-K
Annual Report FY 2016
2016-12-07 English
PRIMARY DOCUMENT
Director's Dealing
2016-11-17 English
PRIMARY DOCUMENT
Director's Dealing
2016-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.